Y Intercept Hong Kong Ltd Sells 4,371 Shares of Cardinal Health, Inc. (NYSE:CAH)

Y Intercept Hong Kong Ltd lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 28.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,832 shares of the company’s stock after selling 4,371 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Cardinal Health were worth $1,281,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in shares of Cardinal Health by 2.1% during the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 52,517 shares of the company’s stock worth $6,211,000 after buying an additional 1,100 shares during the last quarter. Sigma Planning Corp grew its stake in shares of Cardinal Health by 3.6% during the fourth quarter. Sigma Planning Corp now owns 11,844 shares of the company’s stock worth $1,401,000 after buying an additional 413 shares during the last quarter. Transcend Capital Advisors LLC grew its stake in shares of Cardinal Health by 3.6% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company’s stock worth $323,000 after buying an additional 96 shares during the last quarter. Handelsbanken Fonder AB grew its stake in shares of Cardinal Health by 11.6% during the fourth quarter. Handelsbanken Fonder AB now owns 39,783 shares of the company’s stock worth $4,705,000 after buying an additional 4,140 shares during the last quarter. Finally, LMG Wealth Partners LLC grew its stake in shares of Cardinal Health by 0.8% during the fourth quarter. LMG Wealth Partners LLC now owns 90,807 shares of the company’s stock worth $10,740,000 after buying an additional 756 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.4 %

Shares of NYSE CAH opened at $127.31 on Thursday. The firm’s 50-day moving average price is $124.31 and its 200-day moving average price is $117.79. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $132.84. The firm has a market capitalization of $30.75 billion, a P/E ratio of 23.75, a P/E/G ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s payout ratio is presently 37.69%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CAH. JPMorgan Chase & Co. boosted their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a report on Tuesday, January 7th. Citigroup lifted their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. Finally, Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average target price of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.